This inventor holds 1 USPTO granted patent. Top assignees: Nanyang Technological University, National University of Singapore. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 685 
1 out of 857 
Years Active: 2021
Title: Thomas Dick: Innovator in Tuberculosis Treatment
Introduction
Thomas Dick is a notable inventor based in Singapore, SG. He has made significant contributions to the field of medicine, particularly in the treatment of tuberculosis. His innovative approach has led to the development of new compounds that target specific mechanisms in the disease.
Latest Patents
Thomas Dick holds a patent for "Compounds for treating tuberculosis." This invention relates to pyrimidine compounds and compositions designed to treat tuberculosis effectively. The compounds may target the F-domain of F-ATP synthase and can be used in conjunction with existing treatments such as bedaquiline or Q203, enhancing the therapeutic options available for patients.
Career Highlights
Throughout his career, Thomas Dick has worked with prestigious institutions, including Nanyang Technological University and the National University of Singapore. His work has been instrumental in advancing research in the field of infectious diseases, particularly tuberculosis.
Collaborations
Thomas has collaborated with notable colleagues, including Adam Hotra and Kevin Pethe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thomas Dick's contributions to the field of tuberculosis treatment exemplify the impact of innovative thinking in medicine. His work continues to inspire future research and development in combating infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile